MedTrace Logo

Identification of Regional Epidemiological Characteristics and Key Prognostic Factors of Colorectal Cancer in Xinjiang and Shandong

NCT07526090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-04-13

No results posted yet for this study

Summary

This is a multicenter, retrospective, cross-sectional observational study aiming to investigate the 5-year overall survival (OS) rate of colorectal cancer (CRC) patients in Xinjiang and Shandong provinces of China. A total of no less than 500 pathologically confirmed CRC patients from 7 medical centers during January 1, 2016 to December 31, 2020 will be enrolled. We will collect and analyze the demographic characteristics, lifestyle, clinical pathological features, treatment patterns and survival prognosis data of patients, explore the regional differences of CRC and its key prognostic factors, and construct a CRC prognostic prediction model. The results will provide theoretical guidance for clinical practice and the formulation of public health policies.

Conditions

Interventions

OTHER

Retrospective Data Collection

Retrospective collection, collation and statistical analysis of de-identified clinical, pathological, treatment and follow-up data of pathologically confirmed colorectal cancer patients from 7 medical centers in Xinjiang and Shandong provinces from January 1, 2016 to December 31, 2020. The collected data includes demographic characteristics, lifestyle, tumor clinical pathological features, treatment patterns and 5-year overall survival status, for the purpose of analyzing regional epidemiological characteristics and key prognostic factors of colorectal cancer.

Sponsors & Collaborators

  • The Second Affiliated Hospital of Shandong First Medical University

    collaborator OTHER

  • The Affiliated Hospital of Jining Medical University

    collaborator UNKNOWN

  • Xinjiang Medical University

    collaborator OTHER

  • Qianfoshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07526090 on ClinicalTrials.gov